Codeine Industry Research Report 2023

Codeine Industry Research Report 2023


Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.

Highlights

The global Codeine market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Market competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Codeine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Codeine.
The Codeine market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Codeine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Codeine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva

Product Type Insights

Global markets are presented by Codeine type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Codeine are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Codeine segment by Ingredient
Single-ingredient Codeine
Multi-ingredient Medications

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Codeine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Codeine market.
Codeine segment by Application

Narcotic Analgesic
Antitussive
Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Codeine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Codeine and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Codeine industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Codeine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Codeine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Codeine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by ingredient, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Frequently Asked Questions

Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Codeine Market Size (2018-2029) & (US$ Million)
2.2.2 Global Codeine Sales (2018-2029)
2.2.3 Global Codeine Market Average Price (2018-2029)
2.3 Codeine by Ingredient
2.3.1 Market Value Comparison by Ingredient (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Single-ingredient Codeine
1.2.3 Multi-ingredient Medications
2.4 Codeine by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Narcotic Analgesic
2.4.3 Antitussive
2.4.4 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Codeine Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Codeine Sales (M Units) of Manufacturers (2018-2023)
3.3 Global Codeine Revenue of Manufacturers (2018-2023)
3.4 Global Codeine Average Price by Manufacturers (2018-2023)
3.5 Global Codeine Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Codeine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Codeine, Product Type & Application
3.8 Global Manufacturers of Codeine, Date of Enter into This Industry
3.9 Global Codeine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Taiji
4.1.1 Taiji Company Information
4.1.2 Taiji Business Overview
4.1.3 Taiji Codeine Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Taiji Codeine Product Portfolio
4.1.5 Taiji Recent Developments
4.2 Mallinckrodt
4.2.1 Mallinckrodt Company Information
4.2.2 Mallinckrodt Business Overview
4.2.3 Mallinckrodt Codeine Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Mallinckrodt Codeine Product Portfolio
4.2.5 Mallinckrodt Recent Developments
4.3 TEVA
4.3.1 TEVA Company Information
4.3.2 TEVA Business Overview
4.3.3 TEVA Codeine Sales, Revenue and Gross Margin (2018-2023)
4.3.4 TEVA Codeine Product Portfolio
4.3.5 TEVA Recent Developments
4.4 Johnson & Johnson
4.4.1 Johnson & Johnson Company Information
4.4.2 Johnson & Johnson Business Overview
4.4.3 Johnson & Johnson Codeine Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Johnson & Johnson Codeine Product Portfolio
4.4.5 Johnson & Johnson Recent Developments
4.5 Medreich
4.5.1 Medreich Company Information
4.5.2 Medreich Business Overview
4.5.3 Medreich Codeine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Medreich Codeine Product Portfolio
6.5.5 Medreich Recent Developments
4.6 Sanofi Aventis
4.6.1 Sanofi Aventis Company Information
4.6.2 Sanofi Aventis Business Overview
4.6.3 Sanofi Aventis Codeine Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Sanofi Aventis Codeine Product Portfolio
4.6.5 Sanofi Aventis Recent Developments
4.7 Cipla
4.7.1 Cipla Company Information
4.7.2 Cipla Business Overview
4.7.3 Cipla Codeine Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Cipla Codeine Product Portfolio
4.7.5 Cipla Recent Developments
6.8 Hikma
4.8.1 Hikma Company Information
4.8.2 Hikma Business Overview
4.8.3 Hikma Codeine Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Hikma Codeine Product Portfolio
4.8.5 Hikma Recent Developments
4.9 Pharmaceutical Associates
4.9.1 Pharmaceutical Associates Company Information
4.9.2 Pharmaceutical Associates Business Overview
4.9.3 Pharmaceutical Associates Codeine Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Pharmaceutical Associates Codeine Product Portfolio
4.9.5 Pharmaceutical Associates Recent Developments
4.10 Novartis
4.10.1 Novartis Company Information
4.10.2 Novartis Business Overview
4.10.3 Novartis Codeine Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Novartis Codeine Product Portfolio
4.10.5 Novartis Recent Developments
6.11 Apotex
6.11.1 Apotex Company Information
6.11.2 Apotex Codeine Business Overview
6.11.3 Apotex Codeine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Apotex Codeine Product Portfolio
6.11.5 Apotex Recent Developments
6.12 Mylan
6.12.1 Mylan Company Information
6.12.2 Mylan Codeine Business Overview
6.12.3 Mylan Codeine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Mylan Codeine Product Portfolio
6.12.5 Mylan Recent Developments
6.13 Aristo Pharma GmbH
6.13.1 Aristo Pharma GmbH Company Information
6.13.2 Aristo Pharma GmbH Codeine Business Overview
6.13.3 Aristo Pharma GmbH Codeine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Aristo Pharma GmbH Codeine Product Portfolio
6.13.5 Aristo Pharma GmbH Recent Developments
6.14 Lannett Company
6.14.1 Lannett Company Company Information
6.14.2 Lannett Company Codeine Business Overview
6.14.3 Lannett Company Codeine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Lannett Company Codeine Product Portfolio
6.14.5 Lannett Company Recent Developments
6.15 Laboratoire Riva
6.15.1 Laboratoire Riva Company Information
6.15.2 Laboratoire Riva Codeine Business Overview
6.15.3 Laboratoire Riva Codeine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Laboratoire Riva Codeine Product Portfolio
6.15.5 Laboratoire Riva Recent Developments
5 Global Codeine Market Scenario by Region
5.1 Global Codeine Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Codeine Sales by Region: 2018-2029
5.2.1 Global Codeine Sales by Region: 2018-2023
5.2.2 Global Codeine Sales by Region: 2024-2029
5.3 Global Codeine Revenue by Region: 2018-2029
5.3.1 Global Codeine Revenue by Region: 2018-2023
5.3.2 Global Codeine Revenue by Region: 2024-2029
5.4 North America Codeine Market Facts & Figures by Country
5.4.1 North America Codeine Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Codeine Sales by Country (2018-2029)
5.4.3 North America Codeine Revenue by Country (2018-2029)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Codeine Market Facts & Figures by Country
5.5.1 Europe Codeine Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Codeine Sales by Country (2018-2029)
5.5.3 Europe Codeine Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Codeine Market Facts & Figures by Country
5.6.1 Asia Pacific Codeine Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Codeine Sales by Country (2018-2029)
5.6.3 Asia Pacific Codeine Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Codeine Market Facts & Figures by Country
5.7.1 Latin America Codeine Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Codeine Sales by Country (2018-2029)
5.7.3 Latin America Codeine Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Codeine Market Facts & Figures by Country
5.8.1 Middle East and Africa Codeine Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Codeine Sales by Country (2018-2029)
5.8.3 Middle East and Africa Codeine Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Ingredient
6.1 Global Codeine Sales by Ingredient (2018-2029)
6.1.1 Global Codeine Sales by Ingredient (2018-2029) & (M Units)
6.1.2 Global Codeine Sales Market Share by Ingredient (2018-2029)
6.2 Global Codeine Revenue by Ingredient (2018-2029)
6.2.1 Global Codeine Sales by Ingredient (2018-2029) & (US$ Million)
6.2.2 Global Codeine Revenue Market Share by Ingredient (2018-2029)
6.3 Global Codeine Price by Ingredient (2018-2029)
7 Segment by Application
7.1 Global Codeine Sales by Application (2018-2029)
7.1.1 Global Codeine Sales by Application (2018-2029) & (M Units)
7.1.2 Global Codeine Sales Market Share by Application (2018-2029)
7.2 Global Codeine Revenue by Application (2018-2029)
6.2.1 Global Codeine Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Codeine Revenue Market Share by Application (2018-2029)
7.3 Global Codeine Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Codeine Value Chain Analysis
8.1.1 Codeine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Codeine Production Mode & Process
8.2 Codeine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Codeine Distributors
8.2.3 Codeine Customers
9 Global Codeine Analyzing Market Dynamics
9.1 Codeine Industry Trends
9.2 Codeine Industry Drivers
9.3 Codeine Industry Opportunities and Challenges
9.4 Codeine Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Ingredient (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Codeine Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Codeine Sales (M Units) of Manufacturers (2018-2023)
Table 7. Global Codeine Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Codeine Revenue of Manufacturers (2018-2023)
Table 9. Global Codeine Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Codeine Average Price (USD/Unit) of Manufacturers (2018-2023)
Table 11. Global Codeine Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Codeine, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Codeine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Taiji Company Information
Table 17. Taiji Business Overview
Table 18. Taiji Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 19. Taiji Codeine Product Portfolio
Table 20. Taiji Recent Developments
Table 21. Mallinckrodt Company Information
Table 22. Mallinckrodt Business Overview
Table 23. Mallinckrodt Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 24. Mallinckrodt Codeine Product Portfolio
Table 25. Mallinckrodt Recent Developments
Table 26. TEVA Company Information
Table 27. TEVA Business Overview
Table 28. TEVA Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 29. TEVA Codeine Product Portfolio
Table 30. TEVA Recent Developments
Table 31. Johnson & Johnson Company Information
Table 32. Johnson & Johnson Business Overview
Table 33. Johnson & Johnson Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 34. Johnson & Johnson Codeine Product Portfolio
Table 35. Johnson & Johnson Recent Developments
Table 36. Medreich Company Information
Table 37. Medreich Business Overview
Table 38. Medreich Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 39. Medreich Codeine Product Portfolio
Table 40. Medreich Recent Developments
Table 41. Sanofi Aventis Company Information
Table 42. Sanofi Aventis Business Overview
Table 43. Sanofi Aventis Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 44. Sanofi Aventis Codeine Product Portfolio
Table 45. Sanofi Aventis Recent Developments
Table 46. Cipla Company Information
Table 47. Cipla Business Overview
Table 48. Cipla Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 49. Cipla Codeine Product Portfolio
Table 50. Cipla Recent Developments
Table 51. Hikma Company Information
Table 52. Hikma Business Overview
Table 53. Hikma Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 54. Hikma Codeine Product Portfolio
Table 55. Hikma Recent Developments
Table 56. Pharmaceutical Associates Company Information
Table 57. Pharmaceutical Associates Business Overview
Table 58. Pharmaceutical Associates Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 59. Pharmaceutical Associates Codeine Product Portfolio
Table 60. Pharmaceutical Associates Recent Developments
Table 61. Novartis Company Information
Table 62. Novartis Business Overview
Table 63. Novartis Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 64. Novartis Codeine Product Portfolio
Table 65. Novartis Recent Developments
Table 66. Apotex Company Information
Table 67. Apotex Business Overview
Table 68. Apotex Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 69. Apotex Codeine Product Portfolio
Table 70. Apotex Recent Developments
Table 71. Mylan Company Information
Table 72. Mylan Business Overview
Table 73. Mylan Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 74. Mylan Codeine Product Portfolio
Table 75. Mylan Recent Developments
Table 76. Aristo Pharma GmbH Company Information
Table 77. Aristo Pharma GmbH Business Overview
Table 78. Aristo Pharma GmbH Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 79. Aristo Pharma GmbH Codeine Product Portfolio
Table 80. Aristo Pharma GmbH Recent Developments
Table 81. Lannett Company Company Information
Table 82. Lannett Company Business Overview
Table 83. Lannett Company Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 84. Lannett Company Codeine Product Portfolio
Table 85. Lannett Company Recent Developments
Table 86. Laboratoire Riva Company Information
Table 87. Laboratoire Riva Business Overview
Table 88. Laboratoire Riva Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 89. Laboratoire Riva Codeine Product Portfolio
Table 90. Laboratoire Riva Recent Developments
Table 91. Global Codeine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 92. Global Codeine Sales by Region (2018-2023) & (M Units)
Table 93. Global Codeine Sales Market Share by Region (2018-2023)
Table 94. Global Codeine Sales by Region (2024-2029) & (M Units)
Table 95. Global Codeine Sales Market Share by Region (2024-2029)
Table 96. Global Codeine Revenue by Region (2018-2023) & (US$ Million)
Table 97. Global Codeine Revenue Market Share by Region (2018-2023)
Table 98. Global Codeine Revenue by Region (2024-2029) & (US$ Million)
Table 99. Global Codeine Revenue Market Share by Region (2024-2029)
Table 100. North America Codeine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. North America Codeine Sales by Country (2018-2023) & (M Units)
Table 102. North America Codeine Sales by Country (2024-2029) & (M Units)
Table 103. North America Codeine Revenue by Country (2018-2023) & (US$ Million)
Table 104. North America Codeine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Europe Codeine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Europe Codeine Sales by Country (2018-2023) & (M Units)
Table 107. Europe Codeine Sales by Country (2024-2029) & (M Units)
Table 108. Europe Codeine Revenue by Country (2018-2023) & (US$ Million)
Table 109. Europe Codeine Revenue by Country (2024-2029) & (US$ Million)
Table 110. Asia Pacific Codeine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Asia Pacific Codeine Sales by Country (2018-2023) & (M Units)
Table 112. Asia Pacific Codeine Sales by Country (2024-2029) & (M Units)
Table 113. Asia Pacific Codeine Revenue by Country (2018-2023) & (US$ Million)
Table 114. Asia Pacific Codeine Revenue by Country (2024-2029) & (US$ Million)
Table 115. Latin America Codeine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. Latin America Codeine Sales by Country (2018-2023) & (M Units)
Table 117. Latin America Codeine Sales by Country (2024-2029) & (M Units)
Table 118. Latin America Codeine Revenue by Country (2018-2023) & (US$ Million)
Table 119. Latin America Codeine Revenue by Country (2024-2029) & (US$ Million)
Table 120. Middle East and Africa Codeine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 121. Middle East and Africa Codeine Sales by Country (2018-2023) & (M Units)
Table 122. Middle East and Africa Codeine Sales by Country (2024-2029) & (M Units)
Table 123. Middle East and Africa Codeine Revenue by Country (2018-2023) & (US$ Million)
Table 124. Middle East and Africa Codeine Revenue by Country (2024-2029) & (US$ Million)
Table 125. Global Codeine Sales by Ingredient (2018-2023) & (M Units)
Table 126. Global Codeine Sales by Ingredient (2024-2029) & (M Units)
Table 127. Global Codeine Sales Market Share by Ingredient (2018-2023)
Table 128. Global Codeine Sales Market Share by Ingredient (2024-2029)
Table 129. Global Codeine Revenue by Ingredient (2018-2023) & (US$ Million)
Table 130. Global Codeine Revenue by Ingredient (2024-2029) & (US$ Million)
Table 131. Global Codeine Revenue Market Share by Ingredient (2018-2023)
Table 132. Global Codeine Revenue Market Share by Ingredient (2024-2029)
Table 133. Global Codeine Price by Ingredient (2018-2023) & (USD/Unit)
Table 134. Global Codeine Price by Ingredient (2024-2029) & (USD/Unit)
Table 135. Global Codeine Sales by Application (2018-2023) & (M Units)
Table 136. Global Codeine Sales by Application (2024-2029) & (M Units)
Table 137. Global Codeine Sales Market Share by Application (2018-2023)
Table 138. Global Codeine Sales Market Share by Application (2024-2029)
Table 139. Global Codeine Revenue by Application (2018-2023) & (US$ Million)
Table 140. Global Codeine Revenue by Application (2024-2029) & (US$ Million)
Table 141. Global Codeine Revenue Market Share by Application (2018-2023)
Table 142. Global Codeine Revenue Market Share by Application (2024-2029)
Table 143. Global Codeine Price by Application (2018-2023) & (USD/Unit)
Table 144. Global Codeine Price by Application (2024-2029) & (USD/Unit)
Table 145. Key Raw Materials
Table 146. Raw Materials Key Suppliers
Table 147. Codeine Distributors List
Table 148. Codeine Customers List
Table 149. Codeine Industry Trends
Table 150. Codeine Industry Drivers
Table 151. Codeine Industry Restraints
Table 152. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. CodeineProduct Picture
Figure 5. Global Codeine Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Codeine Market Size (2018-2029) & (US$ Million)
Figure 7. Global Codeine Sales (2018-2029) & (M Units)
Figure 8. Global Codeine Average Price (USD/Unit) & (2018-2029)
Figure 9. Single-ingredient Codeine Product Picture
Figure 10. Multi-ingredient Medications Product Picture
Figure 11. Narcotic Analgesic Product Picture
Figure 12. Antitussive Product Picture
Figure 13. Others Product Picture
Figure 14. Global Codeine Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Codeine, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Codeine, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Codeine Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Codeine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Codeine Sales by Region in 2022
Figure 21. Global Codeine Revenue by Region in 2022
Figure 22. North America Codeine Market Size by Country in 2022
Figure 23. North America Codeine Sales Market Share by Country (2018-2029)
Figure 24. North America Codeine Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Codeine Market Size by Country in 2022
Figure 28. Europe Codeine Sales Market Share by Country (2018-2029)
Figure 29. Europe Codeine Revenue Market Share by Country (2018-2029)
Figure 30. Germany Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Codeine Market Size by Country in 2022
Figure 36. Asia Pacific Codeine Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Codeine Revenue Market Share by Country (2018-2029)
Figure 38. China Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Codeine Market Size by Country in 2022
Figure 48. Latin America Codeine Sales Market Share by Country (2018-2029)
Figure 49. Latin America Codeine Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East and Africa Codeine Market Size by Country in 2022
Figure 54. Middle East and Africa Codeine Sales Market Share by Country (2018-2029)
Figure 55. Middle East and Africa Codeine Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Codeine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Codeine Sales Market Share by Ingredient (2018-2029)
Figure 60. Global Codeine Revenue Market Share by Ingredient (2018-2029)
Figure 61. Global Codeine Price (USD/Unit) by Ingredient (2018-2029)
Figure 62. Global Codeine Sales Market Share by Application (2018-2029)
Figure 63. Global Codeine Revenue Market Share by Application (2018-2029)
Figure 64. Global Codeine Price (USD/Unit) by Application (2018-2029)
Figure 65. Codeine Value Chain
Figure 66. Codeine Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Codeine Industry Opportunities and Challenges

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings